Is the desperation of patients with incurable diseases being exploited?

Patients with incurable diseases are more likely to explore experimental treatments, but the unknown safety and efficacy of these treatments cannot be ignored, write Matthew B Flynn, James Flynn, and Ana Palacios

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 381; p. 1337
Main Authors Flynn, Matthew B, Flynn, James, Palacios, Ana
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 12.06.2023
BMJ Publishing Group LTD
Subjects
Amyotrophic lateral sclerosis
Clinical trials
Design
Dietary supplements
Illnesses
Medical research
Motor neurone disease
Opinion
Patients
Pharmaceutical industry
Prescription drugs
Regulatory approval
United States > US
Georgia
Online AccessGet full text

Cover

More Information
Summary:Patients with incurable diseases are more likely to explore experimental treatments, but the unknown safety and efficacy of these treatments cannot be ignored, write Matthew B Flynn, James Flynn, and Ana Palacios
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1756-1833
1756-1833
DOI:10.1136/bmj.p1337